Since inflammation can predispose to tumor, targeting inflammation and the molecules (COX-2 cyclooxygenase 2, NF-kB, VEGF,) involved in inflammatory process could represent a good strategy for cancer prevention and therapy [1,2,3,4], (Table 1). This evidence concerns the gene NFKB1 and neoplasm.